Download PDF
Thromb Haemost 1999; 82(04): 1361-1362
DOI: 10.1055/s-0037-1614393
Letters to the Editor
Schattauer GmbH

Low-molecular Weight Heparin for Treatment of Pulmonary Embolism in a Pregnant Woman

Authors

  • Steven A. Laifer

    1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA

  • Robert J. Stiller

    1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA

  • Gina Dunston-Boone

    1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA

  • John C. G. Whetham

    1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA
Further Information

Publication History

Received 22 April 1999

Accepted after resubmission 15 June 1999

Publication Date:
08 December 2017 (online)

   Permissions and Reprints
Preview

 

 

  • References

  • 1 Casele H, Laifer S, Woelkers D, Venkataramanan R. Changes in the pharmacokinetics of the low molecular weight heparin enoxaparin during pregnancy. Am J Obstet Gynecol (in press).
    PubMed
  • 2 Andersen DR, Ginsberg JS, Burrows R, Brill-Edwards P. Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thrombosis Haemostasis 1991; 65: 248-50.
    PubMedSearch in Google Scholar
  • 3 Horlocker TT, Wedel DJ. Neuraxial block and low-molecular weight heparin: Balancing perioperative analgesia and thromboprophylaxis. Reg Anes Pain Med 1998; 23 (S) 164-177.
    PubMedSearch in Google Scholar